Search Results

You searched for : Merck  

We have more infection-prevention options now but are they actual choices for the people?

There are at least two elements of choice- choices in products, and also choices in terms of where I want it and from whom I ...
Jul 19

India’s first indigenously developed vaccine against cervical cancer will hit the market soon

India’s first indigenously developed human papillomavirus (HPV) vaccine will be soon administered to women in near future. The research and development related to vaccines ...
Sep 02

Biomarker startup Koneksa gains $45 million

Digital biomarker startup Koneksa has raised $45 million in their Series C funding round....
Feb 08

BioMed X Institute and Merck KGaA, Darmstadt, Germany, extend collaboration in Oncology

Corporate News Updates; Pharma Feb 3rd 2022...
Feb 03

HexaHealth and India’s in-patient care segment

Out of the $130 billion spent on healthcare, 60% is spent on in-patient care across private providers alone. Despite its importance and size, the ...
Jan 19

Transcarent raises $200M in Series C funding

California-based healthcare company, Transcarent, raised $200 million in their Series C fund round by Kinnevik and Human Capital. ...
Jan 12

ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel

...
Nov 03

Evaxion Biotech announces Clinical Collaboration to evaluate Keytruda in melanoma patients

Latest news updates...
Oct 26

Merck launches the cosmetic active ingredient RonaCare to strengthen the skin's resilience

Latest pharma updates...
Oct 12

Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106

Latest Pharma Update...
Aug 23

Merck Announces U.S. FDA Approval of VAXNEUVANCE for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older

Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus....
Jul 17

BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in Oncology

Pharma News Update July 8...
Jul 09

Alzheimer's Disease Fast Facts

Facts about the Alzheimer's disease...
Jul 08

LYNPARZA (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Treatments in BRCA1/2-Mutated Advanced Prostate Cancer...
Jun 24

Merck to Participate in the Guggenheim Biopharma Strategy Series

Merck Research Laboratories, is scheduled to participate in a virtual fireside chat at the Guggenheim Biopharma Strategy Series...
Jun 19

Merck Announces Supply Agreement with U.S. Government for Molnupiravir

...
Jun 09

Merck Announces Positive Topline Results from PNEU-DIRECTION (V114-027) and PNEU-PLAN (V114-024)

Phase 3 Pediatric Studies for V114, Merck’s Investigational...
May 22

M2GEN announces new collaboration with Merck to advance Cancer therapies

Another pharma collaboration for the advancement of cancer therapies ...
Mar 22

Debiopharm grants exclusive license to Merck for Xevinapant

This worldwide exclusive license to Merck KGaA, Darmstadt, Germany for the development and commercialization of Xevinapant ...
Mar 03

Lupin Launches Posaconazole Delayed-Release Tablets

Lupin & its AET Pharma US Inc. (part of Tiefenbacher Group) received an approval for its ANDA from the USFDA...
Feb 17

Philips and Merck partner to advance personalized fertility treatment

Royal Philips, a global leader in health technology, today announced a multi-year partnership with Merck, a leading science and technology company, to develop clinical-...
Jan 15

U.S. FDA Accepts for Priority Review the Biologics License Application for V114

Merck announced the U.S. FDA accepted for priority review a Biologics License Application for V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine, for ...
Jan 12

Propanc Biopharma Advances POP1 Joint Research and Drug Discovery Program

The drugs discovery program is for servicing the US$111.2B global Metastatic Cancer market...
Dec 31

LYNPARZA (olaparib) Receives Three New Approvals in Japan

LYNPARZA has been approved in Japan for the treatment of three types of advanced cancer: ovarian, prostate and pancreatic cancer....
Dec 28

A2 Biotherapeutics enters into collaboration agreement With Merck ; cell therapy for solid tumor Cancers

...
Dec 26

25 Matching result(s) found!

-Advertisements-




Trending Now

We have more infection-prevention options now but are they actual choices for the people?July 19, 2024
New humidity-driven membrane to remove carbon dioxide from the airJuly 19, 2024
Introducing the World's First Consent-Based Data-Sharing Framework Built on Open Standards: The Affinidi Iota Framework July 19, 2024
The Power of Green Spaces: Evidence That Parks May Delay Cognitive DeclineJuly 19, 2024
Strengthening Healthcare in India: The Push for Better Coverage with Ayushman BharatJuly 19, 2024
SARV Events & Celebrations Shines at "Edu-Bizz Leadership Summit & Awards 24July 18, 2024
UAE launches global initiative to build 10 hospitals to address critical healthcare gaps as part of Zayed Humanitarian Legacy InitiativeJuly 18, 2024
Geetanjali Homestate Expands Global Presence with the Launch of Geetanjali GlobalJuly 18, 2024
Changes projected in marine fish communities due to climate changeJuly 18, 2024
Understanding the Chandipura Virus Outbreak in Gujarat: A Critical OverviewJuly 18, 2024
Landmark Study Links Severe Endometriosis to Increased Risk of Ovarian CancerJuly 18, 2024
Equipping Healthcare Professionals for Global Opportunities: GIMS Partners with NSDCJuly 18, 2024
Hormone Modulating Therapy for Breast Cancer and Its Link to Lower Alzheimer’s RiskJuly 18, 2024
Multipl Secures $1.5 Million in Additional Funds, Led by Blume Ventures and MIXI Global Investments, JapanJuly 17, 2024
FedEx to empower youth with digital skilling programJuly 17, 2024
Putting people first means following Gandhi's TalismanJuly 17, 2024
American Oncology Institute (AOI) Launches #BreaktheHabit Campaign to Raise Awareness on Head & Neck cancerJuly 17, 2024
Chamraj Tea Estate Launches New Nilgiri Tea Blends: ‘Master Blend,’ ‘Master Blend Ginger Tea,’ and ‘Master Blend Lemon Tea’July 16, 2024
How a Fiber-Rich Diet and Gut Parasites Can Improve Your HealthJuly 16, 2024
LinkedIn: A Double-Edged Sword for Professional GrowthJuly 16, 2024